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The binding of homologous plasma lipoproteins to specific receptor proteins in the plasma membrane of 
human blood platelets was studied by ligand blotting techniques. HDL,, HDL, and LDL showed saturable 
binding to three bands of 156, 130 and 115 kDa, respectively. This binding was not markedly affected by 
the presence or absence of Caz+ nor by covalent modification of lysine and arginine residues of the apopro- 
tein moieties. However, it can be almost completely reversed by the addition of heparin or suramin. 
Platelet Plasma membrane Lipoprotein receptor Ligand blotting ModiJication 
1. INTRODUCTION 
The reactivity of blood platelets at least to some 
degree depends on the amount and composition of 
the plasma lipids and lipoproteins which they con- 
tact in vivo [l-4]. This finding can be partially ex- 
plained by alterations in the composition of the 
platelet plasma membrane in exchange with com- 
mon lipid pools. Isolated platelets, however, are 
quite rapidly stimulated upon addition of lipopro- 
teins [4-61, suggesting direct interaction between 
the latter and partial structures of the throm- 
bocytes. This interaction most likely is mediated 
via specific receptors on the platelet surface. High- 
affinity binding of both HDL and LDL to isolated 
intact platelets has been demonstrated [7,8]. Our 
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findings suggest he existence of a single class of 
binding sites for both subclasses of lipoproteins, 
which displays a higher binding affinity towards 
HDL than for LDL (Ka = 9 x 10’ and 6 x 
10’ M-r, respectively). HDLJ and LDL interfere 
with binding of each other in a noncompetitive 
manner. VLDL, which is not bound in a saturable 
manner, has a similar effect. The characteristics of 
binding and its possible association with 
atherogenesis make it desirable to investigate the 
way by which lipoproteins affect blood platelets. 
Here, the distinct proteins involved in the binding 
of lipoproteins to the platelet surface have been 
identified. 
2. EXPERIMENTAL 
2.1. Materials 
Suramin was kindly provided by Bayer-Austria, 
Vienna. Biotinylated antibodies were from Amer- 
sham (England); all other antisera were from Beh- 
ringwerke (Marburg) or Immuno (Vienna). 
2.2. Preparation of human platelet membranes 
PRP was prepared from ACD-blood within 2 h 
of collection. After removal of erythrocytes and 
repeated washing, platelets were finally suspended 
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in 0.01 M Tris-HCI, pH 7.5 (0.15 M NaCl, 1 mM 
EDTA, 4 mM PMSF), to a concentration of 
2-4 x lo6 platelets/kl. The suspension was 
sonified for a total of 100 s at 0°C (Branson B-30) 
and further treated following the centrifugation 
technique of Barber and Jamieson [9] with minor 
modifications, including the addition of PMSF in 
all steps, and omitting the last centrifugation step. 
The suspension medium for the membrane 
preparation was 15 mM Tris-HCI, pH 7.5, 
0.125 M sucrose, 75 mM NaCI, 1 mM PMSF, 
1 mM EDTA. Lactic dehydrogenase and acid 
phosphatase, respectively, were determined to 
monitor the progress of purification of the mem- 
brane proteins. The corresponding values are in 
good accordance with those obtained by the lysis 
technique [9]. The preparations were stored in ali- 
quots at - 80°C for up to 2 months and thawed at 
0°C immediately before use. 
2.3. Plasma lipoproteins 
Human VLDL, LDL, HDLz and HDLs were 
isolated by sequential ultracentrifugation [lo] and 
used within 1 week following filtration through 
Millipore filters (0.45 pm). Concentrations are ex- 
pressed as protein content, determined by the 
method of Lowry et al. [ll]. Modifications: 
Acetylated lipoproteins were prepared by the 
method of Basu et al. [12]. The degree of acetyla- 
tion of amino groups ranged from 22 to 30070 for 
LDL, and from 62 to 68% for HDL3, respectively, 
as determined by titration of free amino groups 
with TNBS [13]. Labeling with FITC was per- 
formed as in [14]. Noncovalent labeling of the lipid 
phase of lipoproteins with DPH was accomplished 
as in [ 151. Experiments with CHD-modified 
lipoproteins, prepared according to [16], were per- 
formed in borate buffer, pH 7.5. [izSI]Iodinated 
ligands were either prepared by the iodogen 
method [17] or with the Bolton-Hunter reagent 
[ 181. Biotinylation of LDL was performed follow- 
ing [19]. Identical results were obtained following 
modification of the carbohydrate residues by the 
method of Wade et al. [20]. Limited proteolysis 
was achieved by incubation with proteinase K or 
trypsin for 1-6 h. 
2.4. SDS-PAGE 
0.1% SDS-PAGE was performed in 8% 
polyacrylamide slab gels, containing 18% (w/v) 
98 
glycerol. Samples were prepared by incubation 
with 2(rlo SDS for 45 min at room temperature 
without addition of reducing agent. 
2.5. Immunoblotting 
Membrane proteins were transferred to NC ac- 
cording to Towbin et al. [21]. Following blocking 
with 3% casein, the paper was incubated with the 
indicated concentrations of lipoproteins in 1% 
gelatin-PBS for at least 2 h. Biotinylated lipopro- 
teins were visualized by incubation with 
streptavidin-biotinylated-peroxidase complex [20]. 
Bound radioiodinated ligands were detected by 
autoradiography (Kodak X-Omat S). In all other 
cases the NC papers were incubated with anti- 
apolipoprotein antibodies (rabbit or goat). The 
bound antibodies were visualized by ELISA apply- 
ing either peroxidase-labeled anti-rabbit(goat) an- 
tiserum, or biotinylated anti-rabbit(goat) IgG. 
3. RESULTS 
The binding of native LDL to platelet plasma 
membrane proteins is shown in fig.1. The amount 
of lipoprotein associated with individual protein 
bands in each case obviously is concentration- 
dependent. In the vast majority of membrane 
preparations binding to two or three protein bands 
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Fig.1. Visualization of binding of human LDL to 
platelet plasma membrane proteins (140 yg total) 
transferred to nitrocellulose. Concentration of LDL kg 
protein/ml): (a) 0, (b) 4.2, (c) 21. 
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was observed, the corresponding molecular masses 
being 156 f 6, 1.30 + 5, and 115 f 2 kDa. Occa- 
sionally, protein bands corresponding to much 
lower molecular masses also showed abilities to 
bind LDL. (The relative frequency of the various 
lipoprotein-binding protein bands is shown in 
fig.2, reflecting the results with a total of 39 dif- 
ferent membrane preparations.) A number of ex- 
periments was undertaken to investigate the 
specificity of the observed binding reactions. 
Vesicles prepared from phosphatidylcholine with 
and without cholesterol cannot prevent binding of 
LDL. The same observation could be made with 
serum albumin and lipoprotein-depleted plasma. 
Using biotinylated LDL, however, unmodified 
LDL clearly competes with binding with the 
former (fig.3). The specificity of the binding to a 
limited number of defined protein bands is further 
confirmed by the virtual agreement of the results 
obtained with different techniques of visualization 
of bound ligand, using either biotinylated ligand, 
or unmodified LDL with two variants of enzyme- 
linked assay, and, finally, ‘251-labeled ligand. Par- 
tial proteolysis, however, of LDL greatly reduces 
its binding affinity. 
Following another strategy to test the specificity 
of interaction, platelet plasma membrane prepara- 
tions blotted to NC were incubated with LDL, 
adding increasing amounts of polyvalent anti-apo 
B antiserum. Complexing of the antigen clearly ex- 
cluded it from being bound to the membrane pro- 
teins (not shown). HDLz and HDLJ were applied 
as ligands in analogous blotting experiments. Both 
lipoprotein subclasses apparently bind to the pro- 
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Fig.2. Cumulative frequency of LDL binding to protein 
bands depending on their relative mobility in SDS- 
PAGE (indicating the number n of positive findings out 
of a total of 39 experiments). 
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Fig.3. Influence of various parameters on binding of 
LDL to transblotted membrane preparations (235 ,ug 
protein). Incubation was performed with 2.9 ,ug/ml 
LDL alone (a); with the addition of suramin (final 
concentration 0.07 M, b); 2500 units/ml heparin (h); 
phosphatidylcholine vesicles (final concentration of 
phospholipid 225 yg/ml, e); and lipoprotein-depleted 
plasma, diluted 1:20 with PBS (j), respectively. Lane i 
shows the visualization of binding of 0.6 pg/ml LDL by 
means of biotinylated second antibody. 3.5 pg/ml of 
biotinylated LDL were applied without (c) and with the 
addition of 52gg/ml of unmodified LDL (d). CHD- 
modified LDL (f) and acetylated LDL (g) were applied 
at protein concentrations of 4.2 and 5.1 fig/ml, 
respectively. 
tein pattern capable of binding LDL (fig.4). This 
finding is further confirmed by the competition ex- 
periments illustrated in fig.5. Both members of the 
high-density class when applied in relative excess 
can inhibit binding of LDL, and vice versa. This 
effect, however, is least obvious with the protein 
band of -116 kDa. As already revealed by ex- 
periments with intact platelets, the reported in- 
teractions are independent of any divalent cations, 
Ca2’ in particular. The lack of any significant ef- 
fect on binding of the presence or absence of Ca” 
and the addition of EDTA up to 10 mM is obvious 
from fig.4. The amount of bound ligand is, 
however, markedly reduced in the presence of 
moderate concentrations of heparin and, similarly, 
by the addition of suramin to the incubation mix- 
tures (fig.3). 
To investigate the importance of charge and/or 
the relative importance of lysine and arginine 
residues of their protein moieties for the specific 
binding of the various lipoprotein subclasses, ex- 
periments with covalently modified ligands were 
99 
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Fig.4. Binding of 3.3 pg/ml LDL with no additions (a), 
in the presence of 2 mM Ca2+ (b), and presence of 
10 mM EDTA (c). Binding of 5.1 #g/ml HDL3 (d) and 
2.8 pg/ml HDLz (e). 
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Fig.5. Binding of 3.6 pg/ml LDL (a), in the presence of
16pg/ml HDLz (b), 25 pug/ml HDLs (c), 78rg/ml 
HDLt (d) and 125 rg/ml HDL3 (e), respectively. 
undertaken. Modification with CHD and by 
acetylation, respectively, has only a minor effect 
on ligand binding (fig.3f,g). The same applies to 
the coupling to lysine side chains of rather large 
chromophoric groups (by introducing dansyl 
groups or FITC), at least at the degree of modifica- 
tion obtained by us. Similarly, labeling with DPH 
of the lipid moiety of the various lipoproteins does 
not interfere with their binding to the protein 
bands cited above (not shown). 
4. DISCUSSION 
In agreement with binding data obtained with 
intact thrombocytes, lipoproteins with buoyant 
density greater than 1.006 g/ml obviously bind to 
the same set of individual membrane proteins. The 
specificity of this observed binding is thus of 
critical importance. We have shown that only in- 
tact lipoproteins on the one hand, and intact 
plasma membrane proteins on the other, are 
capable of interacting sufficiently. Binding cannot 
be achieved by lipid vesicles alone, nor by lipopro- 
teins significantly changed in their apoprotein 
structure, nor after complexing the latter with 
polyvalent anti-apoprotein antibodies. Saturability 
of the binding and inhibition of binding by ex- 
cessive amounts of competing lipoproteins (in- 
cluding VLDL) deliver additional evidence for the 
biological significance of the described 
phenomena. 
The existence of at least three different protein 
bands revealing binding affinity towards plasma 
lipoproteins either reflects heterogeneity of 
binding sites or partial degradation of a single 
(glyco)protein. From binding isotherms nothing in 
favour of the former possibility can be derived, but 
this cannot, of course, rule out microheterogeneity 
of receptor sites. Aviram et al. [22] proposed a 
model comprising both high- and low-affinity sites 
for LDL. Their statements are hard to assess, 
however, since most of their data reflect ‘ac- 
cumulation’ of lipoproteins rather than binding 
due to the rather long times of incubation applied. 
Additionally, the effects of various lipoproteins 
(native and modified) described by them in part are 
contradictory [4,22,23]; the experiment demon- 
strating replacement of bound 1251-labeled LDL by 
unlabeled LDL lacks any indication of biphasic 
binding behaviour [22]. According to our inter- 
pretation there still is no direct evidence of the 
mutual existence of two different classes of recep- 
tor sites. The existence of more than one single 
band showing affinity most likely is caused by par- 
tial hydrolysis. The finding that the band of 
115 kDa shows some nonspecific binding, and the 
absence of smaller bands in most preparations, are 
in support of this interpretation. Very recently, 
Hassall and Bruckdorfer [24] reported the 
visualization of a single protein binding “‘1-LDL, 
obtained from a differently prepared platelet mem- 
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brane fraction. As far as the biochemical proper- 
ties are concerned, no differences can be detected 
between the various binding proteins. None needs 
Ca2+ or any other divalent cation to bind any class 
of lipoprotein. Covalent modification of positively 
charged amino acid side chains has little or no ef- 
fect at all. Even the modification with rather bulky 
chromophoric groups involves little hindrance for 
binding. The protein@) under investigation thus 
obviously do not depend on the binding sequence 
responsible for binding of a~033 and apoE in 
various tissues [25,26]. Some similarity appears to 
exist with receptor proteins for HDL in cultured 
rat and porcine hepatocytes, and in rat intestinal 
mucosa, respectively f27,2g]. 
Major controversy exists with respect to the 
biological significance of the observed high- 
affinity binding of lipoproteins [22,29]. Most of 
the effects plasma lipoproteins have been reported 
to exert on platelet activity are observed at concen- 
trations si~ificantly higher than those leading to 
saturation of high-af~nity binding sites. However, 
this does not take into account the interference 
displayed by different classes of lipoproteins when 
simultaneously present, as in vivo. We have shown 
that competition for sites leads to decreasing ap- 
parent affinities, which in turn means that satura- 
tion of lipoprotein receptors will not occur at con- 
centrations of ligands markedly below the range of 
physiological lipoprotein concentrations. Even 
then, variations in the relative amounts of the dif- 
ferent classes of lipoproteins consequently would 
lead to changes in the pattern of bound Xigands. 
We propose the existence of a single type of recep- 
tor protein assuming different functional forms 
depending on the nature of the bound ligands, This 
hypothesis is currently being tested with solubilized 
receptor protein. 
~ndependently~ differences with respect to the 
chemical constitution of the lipoproteins used in 
different sets of experiments may account for some 
results exhibiting poor reproducibility. The capaci- 
ty to bind I-alkyd-2-acetyl-sn-glycero-3-phospho- 
choline ~pl~telet-activating factor), in particular, 
as documented by Kulikov and Bergelson f30], 
could give rise to activation of platelets with com- 
plex kinetics. The amount of lipid peroxides within 
the lipoproteins, on the other hand, largely depend- 
ing on the method of preparation, shows some 
negative effect on specific binding ~unpublished~~ 
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